British Gynaecological Cancer Society (BGCS) vulval cancer guidelines: Recommendations for practice.

Chemotherapy Lichen sclerosis Radiotherapy Surgery Vulval cancer Vulvar intraepithelial neoplasia

Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 13 04 2020
revised: 15 05 2020
accepted: 26 05 2020
pubmed: 6 7 2020
medline: 15 5 2021
entrez: 5 7 2020
Statut: ppublish

Résumé

The purpose of this guideline is to collate evidence and propose evidence-based guidelines for the diagnosis and management of adult patients with vulva carcinoma treated in the UK. Malignant melanoma may present via similar routes and will be discussed. The reader is referred to the Ano-uro-genital Mucosal Melanoma Full Guideline [1] for more detailed recommendations. The management of vulval sarcoma is outside of the scope of this guideline. For further information, including details of guideline development and GRADE of recommendations, please see BGCS website for details (https://www.bgcs.org.uk/professionals/guidelines-for-recent-publications/).

Identifiants

pubmed: 32620514
pii: S0301-2115(20)30338-9
doi: 10.1016/j.ejogrb.2020.05.054
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

502-525

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Jo Morrison (J)

Department of Gynaecological Oncology, GRACE Centre, Musgrove Park Hospital, Somerset NHS Foundation Trust, Taunton, TA1 5DA, UK. Electronic address: jo.morrison@tst.nhs.uk.

Peter Baldwin (P)

Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust, Cambridge, UK.

Lynn Buckley (L)

Department of Gynae-Oncology, Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust, East Yorkshire, HU16 5JQ, UK.

Lucy Cogswell (L)

Consultant Plastic & Reconstructive Surgeon, Department of Plastic &Reconstructive Surgery, Oxford University Hospitals NHS Trust, Headington, Oxford, OX3 9DU, UK.

Katharine Edey (K)

Centre for Women's Health Royal Devon and Exeter NHS Foundation Trust, Barrack Road, Exeter EX2 5DW, UK.

Asma Faruqi (A)

Department of Cellular Pathology, The Royal London Hospital, Barts Health NHS Trust, London, E1 2ES, UK.

Raji Ganesan (R)

Department of Cellular Pathology, Birmingham Women's Hospital, Birmingham, B15 2TG, UK.

Marcia Hall (M)

Dept Medical Oncology, Mount Vernon Cancer Centre, Rickmansworth Road, Northwood, Middx HA6 2RN, UK.

Kathryn Hillaby (K)

Department Gynaecological Oncology, Cheltenham General Hospital, Gloucestershire, Hospitals NHS Foundation Trust, GL53 7AN, UK.

Nick Reed (N)

Beatson Oncology Centre, Gartnavel General Hospital, 1053 Great Western Road, Glasgow, G12 0YN, Scotland, UK.

Phil Rolland (P)

Department Gynaecological Oncology, Cheltenham General Hospital, Gloucestershire Hospitals NHS Foundation Trust, GL53 7AN, UK.

Christina Fotopoulou (C)

Gynaecologic Oncology, Imperial College London Faculty of Medicine, London, SW7 2DD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH